Please try another search
For the six months ended 30 June 2019, HemaCare Corporation revenues increased 49% to $19.5M. Net income increased from $2.1M to $4.5M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from OTHER INCOME (EXPENSE) decrease from $3K (expense) to $51K (income). Basic Earnings per Share excluding Extraordinary Items increased from $0.18 to $0.33.
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Revenue | 19.45 | 15.44 | 13.07 | 11.55 |
Gross Profit | 10.22 | 8.23 | 7.43 | 6.12 |
Operating Income | 4.12 | 3.31 | 2.92 | 2.85 |
Net Income | 4.47 | 2.39 | 2.13 | 3.88 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Total Assets | 32.77 | 28.23 | 20.04 | 17.45 |
Total Liabilities | 6.32 | 7.11 | 3 | 2.75 |
Total Equity | 26.45 | 21.12 | 17.05 | 14.7 |
Period Ending: | Jun 30, 2019 | Dec 31, 2018 | Jun 30, 2018 | Dec 31, 2017 |
---|---|---|---|---|
Period Length: | 6 Months | 12 Months | 6 Months | 12 Months |
Cash From Operating Activities | 1.32 | 8.04 | 1.18 | 3.32 |
Cash From Investing Activities | -0.9 | -8.21 | -0.1 | -0.12 |
Cash From Financing Activities | 0.22 | 1.2 | -0.06 | 3.77 |
Net Change in Cash | 0.64 | 1.02 | 1.03 | 6.98 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review